Medicine and Genomics IMED Biotech Unit
Ruth March, PhD, is Senior Vice-President of AstraZeneca’s Precision Medicine and Genomics function, including over 110 diagnostic and genomics experts across the globe. As a member of the senior leadership team in AstraZeneca’s Innovative Medicines & Early Development Biotech Unit, I am accountable for delivering diagnostics across AstraZeneca’s R&D pipeline to match targeted medicines to those patients most likely to benefit. I also lead AstraZeneca/ MedImmune’s Genomics Initiative, which aims to transform drug discovery and development by analysing up to 2 million genomes.
Respiratory, Inflammation & Autoimmunity